The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing
暂无分享,去创建一个
Zhenming Liu | Liang Zhao | Hongwei Jin | Qiyao Luo | Jianxing Hu | Liangren Zhang | Hongwei Jin | L. Zhang | Zhen-ming Liu | Liang Zhao | Jianxing Hu | Qiyao Luo | Zhenming Liu
[1] Weida Tong,et al. In silico drug repositioning: what we need to know. , 2013, Drug discovery today.
[2] Mire Zloh,et al. Target fishing and docking studies of the novel derivatives of aryl-aminopyridines with potential anticancer activity. , 2012, Bioorganic & medicinal chemistry.
[3] Richard M. Jackson,et al. ReverseScreen3D: A Structure-Based Ligand Matching Method To Identify Protein Targets , 2011, J. Chem. Inf. Model..
[4] C. Ung,et al. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? , 2003, Natural product reports.
[5] B Testa,et al. In silico pharmacology for drug discovery: applications to targets and beyond , 2007, British journal of pharmacology.
[6] Anders Wallqvist,et al. Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach , 2012, J. Chem. Inf. Model..
[7] Didier Rognan,et al. Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems , 2008, J. Chem. Inf. Model..
[8] J. Medina-Franco,et al. Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.
[9] B. Tidor,et al. Rational Approaches to Improving Selectivity in Drug Design , 2012, Journal of medicinal chemistry.
[10] Xian Liu,et al. In Silico target fishing: addressing a “Big Data” problem by ligand-based similarity rankings with data fusion , 2014, Journal of Cheminformatics.
[11] Sean Ekins,et al. In silico repositioning of approved drugs for rare and neglected diseases. , 2011, Drug discovery today.
[12] Eric J. Deeds,et al. Structural Properties of Non-Traditional Drug Targets Present New Challenges for Virtual Screening , 2013, J. Chem. Inf. Model..
[13] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[14] A. Bender,et al. Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data , 2007, ChemMedChem.
[15] R. Rothman,et al. Serotonergic drugs and valvular heart disease , 2009, Expert opinion on drug safety.
[16] Maurizio Recanatini,et al. The role of fragment-based and computational methods in polypharmacology. , 2012, Drug discovery today.
[17] Byron L. Lam,et al. Acute Effects of Sildenafil (Viagra) on Blue‐on‐Yellow and White‐on‐White Humphrey Perimetry , 2000, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[18] Didier Rognan,et al. Structure‐Based Approaches to Target Fishing and Ligand Profiling , 2010, Molecular informatics.
[19] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[20] Matthias Rarey,et al. Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening , 2014, J. Chem. Inf. Model..
[21] Ram Samudrala,et al. Novel paradigms for drug discovery: computational multitarget screening. , 2008, Trends in pharmacological sciences.
[22] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[23] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[24] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[25] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[26] Xin Chen,et al. The interprotein scoring noises in glide docking scores , 2012, Proteins.
[27] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[28] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[29] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[30] David B Jackson,et al. Drug profiling: knowing where it hits. , 2010, Drug discovery today.
[31] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[32] Tom Halgren,et al. New Method for Fast and Accurate Binding‐site Identification and Analysis , 2007, Chemical biology & drug design.
[33] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[34] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[35] Wang,et al. Proteomics in drug discovery. , 1999, Drug discovery today.
[36] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[37] Adrià Cereto-Massagué,et al. Tools for in silico target fishing. , 2015, Methods.
[38] Y. Z. Chen,et al. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. , 2001, Journal of molecular graphics & modelling.
[39] Paul N. Mortenson,et al. Diverse, high-quality test set for the validation of protein-ligand docking performance. , 2007, Journal of medicinal chemistry.
[40] Sudipto Mukherjee,et al. Evaluation of DOCK 6 as a pose generation and database enrichment tool , 2012, Journal of Computer-Aided Molecular Design.
[41] I. Khanna,et al. Drug discovery in pharmaceutical industry: productivity challenges and trends. , 2012, Drug discovery today.
[42] J. Mestres,et al. On the origins of drug polypharmacology , 2013 .